LEGN Legend Biotech Corporation
Healthcare$29.37+4.93%ClosedMarket Cap: $5.43B
As of 2026-05-25
Institutional Ownership Summary
Investors Holding
215
13F Shares
87,580,091
Ownership %
97.1%
New Positions
35
Increased Positions
106
Closed Positions
36
Reduced Positions
64
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| Harbor Health Care ETF (MEDI) | 60,189 | 3.94% | |
| Loncar Cancer Immunotherapy ETF | 38,005 | 3.20% | |
| Matthews Emerging Markets Discovery Active ETF MEMS | 25,297 | 2.30% | |
| Global X - Genomics & Biotechnology ETF | 59,071 | 2.27% | |
| Tema Oncology ETF | 178,283 | 1.87% | |
| Fidelity Disruptive Medicine ETF | 55,400 | 1.70% | |
| Matthews Emerging Markets Sustainable Future Active ETF EMSF | 37,540 | 1.70% | |
| Virtus Biotech ETF | 37,824 | 1.29% | |
| KraneShares MSCI All China Health Care Index ETF | 31,538 | 0.68% | |
| iShares Biotechnology ETF | 983,928 | 0.22% | |
| WisdomTree China ex-State-Owned Enterprises Fund | 32,054 | 0.11% | |
| State Street SPDR S&P Kensho New Economies Composite ETF | 117,559 | 0.09% | |
| iShares MSCI China ETF | 183,604 | 0.05% | |
| State Street SPDR S&P China ETF | 11,769 | 0.04% | |
| 189,238 | 0.03% | ||
| 218,506 | 0.02% | ||
| 218,506 | 0.02% | ||
| iShares MSCI Emerging Markets Asia ETF | 10,123 | 0.02% | |
| Aethlon Medical, Inc. | 80,191 | 0.02% | |
| State Street SPDR Portfolio Emerging Markets ETF | 91,455 | 0.01% |